Danaher Corporation (DHR) has been in the headlines recently due to a series of transactions and partnerships. The company's shares have been sold and acquired by multiple investing firms, such as
RFG Advisory LLC,
Fire Capital Management LLC, and
Centaurus Financial Inc. Notably, Danaher announced a partnership with
AstraZeneca PLC (AZN) pushing towards scaling next-gen precision medicine tests. Moreover, it appears to be favored by financial analysts and hedge funds alike. However,
Danaher's stock has fluctuated, experiencing a 4.8% decrease since its last earnings report despite plenty of positive news. Additionally, discussions around
Danaher have appeared on the radar of influential personalities in the business world, like Jim Cramer. Overall, Wall Street is significantly bullish on
Danaher, as demonstrated by its frequent appearance among stocks with buy ratings.
Danaher Corporation DHR News Analytics from Fri, 10 Jan 2025 08:00:00 GMT to Sat, 07 Jun 2025 19:38:05 GMT -
Rating 7
- Innovation -3
- Information 8
- Rumor -1
